Sarcoma: open trials in New Zealand

6 open trials have a site in New Zealand. Registry data; only the trial team decides who can take part.

NCT06345729
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Auckland City Hospital ( Site 3400), Auckland
Registry updated 2026-10-26
NCT07746141
A First-in-Human Study Investigating BG-85738 Alone or in Combination With Other Antitumor Agents in Patients With Advanced or Metastatic Solid Tumors With Rat Sarcoma Virus (RAS) Mutations
Trial Treatment · Phase 1 · BeOne Medicines
Auckland City Hospital, Auckland
Registry updated 2026-10-23
NCT06884618
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)
Trial Treatment · Phase 1 · Hoffmann-La Roche
New Zealand Clinical Research - Auckland, Auckland · New Zealand Clinical Research - Christchurch, Christchurch
Registry updated 2026-09-28
NCT05235165
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Trial Treatment · Phase 3 · Children's Oncology Group
Christchurch Hospital, Christchurch · Starship Children's Hospital, Grafton
Registry updated 2026-08-25
NCT05304585
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
Trial Treatment · Phase 3 · Children's Oncology Group
Christchurch Hospital, Christchurch · Starship Children's Hospital, Grafton
Registry updated 2026-08-25
NCT04625907
FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma
Trial Treatment · Phase 1/2 · University of Birmingham
Starship Children's Health, Auckland · Christchurch Hospital, Christchurch
Registry updated 2024-05-23

All Sarcoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error

Sarcoma: open trials in New Zealand

A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

A First-in-Human Study Investigating BG-85738 Alone or in Combination With Other Antitumor Agents in Patients With Advanced or Metastatic Solid Tumors With Rat Sarcoma Virus (RAS) Mutations

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)

Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma

FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma